Literature DB >> 21798387

The complex interplay between cholesterol and prostate malignancy.

Keith R Solomon1, Michael R Freeman.   

Abstract

Research into the role of cholesterol and prostate disease has been ongoing for many years, but our mechanistic and translational understanding is still poor. Recent evidence indicates that cholesterol-lowering drugs reduce the risk of aggressive prostate cancer. This article reviews the literature on the relationship between circulating cholesterol and prostate cancer. The data strongly point to hypercholesterolemia as a risk factor for prostate cancer progression and suggest clinical opportunities for the use of cholesterol-lowering therapies to alter disease course.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21798387      PMCID： PMC3146741          DOI： 10.1016/j.ucl.2011.04.001

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  183 in total

1.  Effects of testosterone and castration on cholesteremia and atherogenesis in chicks on high fat, high cholesterol diets.

Authors:  R PICK; J STAMLER; S RODBARD; L N KATZ
Journal:  Circ Res       Date:  1959-03       Impact factor: 17.367

2.  The risk of cancer in users of statins.

Authors:  Matthijs R Graaf; Annette B Beiderbeck; Antoine C G Egberts; Dick J Richel; Henk-Jan Guchelaar
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

3.  Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.

Authors:  Edith D Beishuizen; Marcel A van de Ree; J Wouter Jukema; Jouke T Tamsma; J Carel M van der Vijver; A Edo Meinders; Hein Putter; Menno V Huisman
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

Review 4.  Statins and risk of cancer: a systematic review and metaanalysis.

Authors:  Danielle R L Browning; Richard M Martin
Journal:  Int J Cancer       Date:  2007-02-15       Impact factor: 7.396

5.  Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin.

Authors:  J R Downs; M Clearfield; H A Tyroler; E J Whitney; W Kruyer; A Langendorfer; V Zagrebelsky; S Weis; D R Shapiro; P A Beere; A M Gotto
Journal:  Am J Cardiol       Date:  2001-05-01       Impact factor: 2.778

6.  Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

Authors:  Timo E Strandberg; Kalevi Pyörälä; Thomas J Cook; Lars Wilhelmsen; Ole Faergeman; Gudmundur Thorgeirsson; Terje R Pedersen; John Kjekshus
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

7.  Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.

Authors:  H Tulinius; N Sigfússon; H Sigvaldason; K Bjarnadóttir; L Tryggvadóttir
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-11       Impact factor: 4.254

8.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

9.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Authors:  Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more
  23 in total

1.  Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms?

Authors:  Mark A Moyad
Journal:  Asian J Androl       Date:  2011-12-26       Impact factor: 3.285

2.  Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells.

Authors:  Yuyang Sun; Pramod Sukumaran; Archana Varma; Susan Derry; Abe E Sahmoun; Brij B Singh
Journal:  Biochim Biophys Acta       Date:  2014-04-25

3.  Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.

Authors:  Byron H Lee; Margaret G Taylor; Peggy Robinet; Jonathan D Smith; Jessica Schweitzer; Ephraim Sehayek; Sara M Falzarano; Cristina Magi-Galluzzi; Eric A Klein; Angela H Ting
Journal:  Cancer Res       Date:  2012-12-11       Impact factor: 12.701

4.  Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications.

Authors:  Maria I Van Rompay; Keith R Solomon; J Curtis Nickel; Gayatri Ranganathan; Philip W Kantoff; John B McKinlay
Journal:  Eur J Cancer       Date:  2019-03-06       Impact factor: 9.162

Review 5.  Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

Authors:  Kaylin M McMahon; Linda Foit; Nicholas L Angeloni; Francis J Giles; Leo I Gordon; C Shad Thaxton
Journal:  Cancer Treat Res       Date:  2015

6.  The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer.

Authors:  Anita Hryniewicz-Jankowska; Katarzyna Augoff; Aleksander F Sikorski
Journal:  Exp Biol Med (Maywood)       Date:  2019-10

Review 7.  Cholesterol and prostate cancer.

Authors:  Kristine Pelton; Michael R Freeman; Keith R Solomon
Journal:  Curr Opin Pharmacol       Date:  2012-07-21       Impact factor: 5.547

8.  Shared common variants in prostate cancer and blood lipids.

Authors:  Ole A Andreassen; Verena Zuber; Wesley K Thompson; Andrew J Schork; Francesco Bettella; Srdjan Djurovic; Rahul S Desikan; Ian G Mills; Anders M Dale
Journal:  Int J Epidemiol       Date:  2014-04-30       Impact factor: 7.196

Review 9.  The current evidence on statin use and prostate cancer prevention: are we there yet?

Authors:  Mahmoud A Alfaqih; Emma H Allott; Robert J Hamilton; Michael R Freeman; Stephen J Freedland
Journal:  Nat Rev Urol       Date:  2016-10-25       Impact factor: 14.432

10.  Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.

Authors:  Miriam B Ishak-Howard; Linda A Okoth; Kathleen A Cooney
Journal:  Urology       Date:  2014-04-16       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.